Epic Build / Desired Build Test Compendium
Welcome to the new Northwell Health Labs Epic Build / Desired Build Test Directory! Please email ClinicalLabInformatics@northwell.edu with any typos, corrections or issues.

OnkoSight NGS AML Panel Epic Compendium  

Desired Epic Build * = editable field  

Cerner Primary Mnemonic: OnkoSight AML Seq. Pnl
PDM 1659925
Informatics - WorkgroupFlow/Mol/Cytog - No Subgroup
Synonyms *
Display Name *OnkoSight NGS AML Panel
Specimen Sources (combined Order Entry and Specimen Navigator) *
Specimen Types (combined Order Entry and Specimen Navigator) *
Blood
Body Fluids (types sent through AOEs)
Specimen Navigator Specimen Types
Specimen Navigator Specimen Sources
Specimen Navigator Short NameOnkoAML
Ordering info (EPIC SmartText)Tumor sequencing by NGS detecting mutations in 30 genes associated with AML. Mutations often have prognostic significance, may confer  resistance to FDA approved therapies, or may qualify patients for late-stage clinical trials.
IP Orderable (inpatient) Yes
OP Orderable (outpatient) Yes
AOEs *

AP AOEs
Special History No
Build Comments
Filter *
Cerner Site RestrictBio Reference Laboratory
BioReference Health LLC
Northwell Health Laboratories
Cerner Results

Result Desc Result display Result PDM
Therapeutic and Prognostic Associations Therapeutic and Prognostic Associations 237540A
Clinical trials 1 Clinical trials 1 237540E
Methods: Methods: 237540H
Allele Frequencies: Allele Frequencies: 237540M
Clinical trials 2 Clinical trials 2 237540F
References 2 References 2 237540J
Detailed genetic interpretation 2 Detailed genetic interpretation 2 237540D
Interpretation summary Interpretation summary 237540B
Addendum Addendum 237540L
References 1 References 1 237540I
Report footer Report footer 237540K
Technical summary Technical summary 237540G
OnkoSight AML Seq. Pnl Onko AML Seq 1659925A
Detailed genetic interpretation 1 Detailed genetic interpretation 1 237540C

Actual Epic Build 6/26/2025

PROCEDURE ID 189675
PDM 1659925
ORDER DISPLAY NAME OnkoSight NGS AML Panel
PROCEDURE NAME ONKOSIGHT NGS AML PANEL
PROCEDURE MASTER NUMBER LAB4138
SHORT PROCEDURE NAME ONKOSIGHT NGS AML PANEL
CATEGORY CODE 21.0
CATEGORY CODE RECORD NAME LAB MOLECULAR DIAGNOSTICS ORDERABLES
SYNONYMS ACUTE MYELOID LEUKEMIA
CLINICALLY ACTIVE Yes
ORDERABLE Yes
PERFORMABLE Yes
FILTER GENOMICS
REFERENCE LINK URL https://labs.northwell.edu/epic/test/189675
ORDERING INSTRUCTIONS
DEFAULT SPECIMEN TYPE
SPECIMEN TYPE PICK LIST Bone Marrow
SPECIMEN TYPE LIST Bone
Blood
OP SPECIMEN TYPE LIST
SPECIMEN SOURCE PICK LIST Bone Marrow
SPECIMEN SOURCE DEFAULT - MALE
SPECIMEN SOURCE DEFAULT - FEMALE
SPECIMEN SOURCE LIST
OP SPECIMEN SOURCE LIST
IP LAB TEST COMPONENTS FOR REPORT
OP LAB TEST COMPONENTS FOR REPORT
ORDER QUESTIONS ["3045300170", "3045300171", "3045300173", "3048500000"]
ORDER QUESTIONS RECORD NAME NH IP HOME COLLECT DATE
NH IP HOME COLLECT DAYS
NH IP HOME COLLECT MEDICALLY NECESSARY
INPATIENT ORDER QUESTIONS ["3048500000"]
INPATIENT ORDER QUESTIONS RECORD NAME
ORDER SPECIFIC QUESTION OVERRIDE
INPATIENT QUESTION OVERRIDE
LOCATION RESTRICT LIST IP
LOCATION RESTRICT LIST IP RECORD NAME
LOCATION RESTRICT LIST INCLUDE IP
LOCATION RESTRICT LIST OP
LOCATION RESTRICT LIST OP RECORD NAME
LOCATION RESTRICT LIST INCLUDES OP
EDP AMB ORDER SPECIFIC QUESTIONS RECORD NAME NH IP PATIENT COMPLETED CONSENT
EDP IP ORDER SPECIFIC QUESTIONS RECORD NAME NH IP PATIENT COMPLETED CONSENT
EDP IP SPECIMEN SOURCE
EDP OP SPECIMEN SOURCE
EDP IP SPECIMEN TYPE
EDP OP SPECIMEN TYPE
DERIVED EDP IP BUTTONS S
DERIVED EDP IP BUTTONS T
DERIVED EDP OP BUTTONS S
DERIVED EDP OP BUTTONS T
IP ORDERABLE
OP ORDERABLE
STANDARD LAB COMPONENTS
STANDARD LAB COMPONENTS RECORD NAME
COMPONENT DATA REQUIREMENT
EPIC OP AOEs

Question IDQuestion NameQuestionResponse TypeResponse ListRequire Response
3045300170 NH IP HOME COLLECT DATE Start Date Date Yes
3045300171 NH IP HOME COLLECT DAYS Days Custom List Monday
Tuesday
Wednesday
Thursday
Friday
Saturday
Sunday
Yes
3045300173 NH IP HOME COLLECT MEDICALLY NECESSARY Medically Necessary? Yes/No Yes
3048500000 NH IP PATIENT COMPLETED CONSENT Patient completed consent? Yes/No Yes
EPIC IP AOEs

Question IDQuestion NameQuestionResponse TypeResponse ListRequire Response
3048500000 NH IP PATIENT COMPLETED CONSENT Patient completed consent? Yes/No Yes
EPIC Components (results - crosswalked through Cerner)

Component IDComponent NameBase NameCommon NameExternal NameCerner Result PDM
3047804957.0 THERAPEUTIC AND PROGNOSTIC ASSOCIATIONS THERPROGASS THERAPEUTIC AND PROGNOSTIC ASSOCIATIONS Therapeutic And Prognostic Associations 237540A
3047801844.0 CLINICAL TRIALS 1 : CLINTRIAL CLINICAL TRIALS 1 Clinical Trials 1 : 237540E
3048100148.0 METHODS METHODS METHODS Methods 237540H
3047800914.0 ALLELE FREQUENCIES: ALLELE ALLELE FREQUENCIES Allele Frequencies: 237540M
3047801845.0 CLINICAL TRIALS 2 : CLINTRIAL CLINICAL TRIALS 2 Clinical Trials 2 : 237540F
3047804494.0 REFERENCES 2 REF2 REFERENCES 2 References 2 237540J
3047802137.0 DETAILED GENETIC INTERPRETATION 2 : DETAILGENINT DETAILED GENETIC INTERPRETATION 2 Detailed Genetic Interpretation 2 : 237540D
3047803091.0 INTERPRETATION SUMMARY INTERP INTERPRETATION SUMMARY Interpretation Summary 237540B
3047800865.0 ADDENDUM : ADDENDUM ADDENDUM 237540L
3047804493.0 REFERENCES 1 REF1 REFERENCES 1 References 1 237540I
3048100147.0 REPORT FOOTER RPTFOOTER REPORT FOOTER Report Footer 237540K
3047804921.0 TECHNICAL SUMMARY : TECHSUM TECHNICAL SUMMARY Technical Summary : 237540G
3047808285.0 ONCOGENE DX ONCOGENE ONCOGENE DX Oncogene Dx 1659925A
3047802136.0 DETAILED GENETIC INTERPRETATION 1 DETAILGENINT DETAILED GENETIC INTERPRETATION 1 Detailed Genetic Interpretation 1 237540C